Paper19468024
Reversal of neuromuscular block.
Srivastava A and 1 other. Br J Anaesth, 2009. Cited by 118 papers, by iCite.
Cite this record
ConductScience Library. Reversal of neuromuscular block. Papers, record 19468024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19468024
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholinesterase Inhibitors | Major topic |
| Cyclodextrins | Major topic |
| Neuromuscular Blockade | Major topic |
| Neuromuscular Blocking Agents | Major topic |
| Neuromuscular Junction | Major topic |
| Anesthesia Recovery Period | |
| Animals | |
| Clinical Trials as Topic | |
| Humans | |
| Postoperative Complications | |
| Sugammadex | |
| gamma-Cyclodextrins |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01690338 | A Study of Residual Curarization Incidence in China | Background | ClinicalTrials.gov | |
| NCT04236050 | Continuous Infusion and Bolus Doses of Rocuronium During Lumbal Discectomy, Muscle Strength and Patient Recovery | Results | ClinicalTrials.gov |
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42889689 | Comparison of Sugammadex and Neostigmine for Reversal of Vecuronium-Induced Neuromuscular Blockade in Pediatric Patients: A Prospective Randomized Study. | Cureus | 2026 | https://conductscience.org/library/papers/42889689 | PubMed |
| 42750962 | Clinical application of sugammadex in renal impairment: pharmacokinetics and pharmacodynamics. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42750962 | PubMed |
| 42739675 | Impact of Sugammadex on Clinical and Patient-Centered Outcomes: Beyond Neuromuscular Recovery. | J Clin Med | 2026 | https://conductscience.org/library/papers/42739675 | PubMed |
| 42317954 | The Effect of Sugammadex Versus Neostigmine on Postoperative Cognitive Recovery: A Systematic Review and Meta-Analysis. | Cureus | 2026 | https://conductscience.org/library/papers/42317954 | PubMed |
| 42306367 | Recurarization in the Post-anesthesia Care Unit One Hour After Sugammadex Administration: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42306367 | PubMed |
| 42226831 | Sugammadex Versus Neostigmine: A Comparative Study of Efficacy and Safety in the Cath Lab. | Cureus | 2026 | https://conductscience.org/library/papers/42226831 | PubMed |
| 42135214 | Current recommendations for preventing residual neuromuscular blockade. | Anesth Pain Med (Seoul) | 2026 | https://conductscience.org/library/papers/42135214 | PubMed |
| 41913738 | Low-Dose Neostigmine at 0.7 Train-of-Four Ratio Safely Accelerates Neuromuscular Recovery: A Prospective Observational Study. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41913738 | PubMed |
| 41629787 | Sugammadex and intraocular pressure: systematic review with meta-analysis and trial sequential analysis. | BMC Anesthesiol | 2026 | https://conductscience.org/library/papers/41629787 | PubMed |
| 41175280 | Association Between Sugammadex Use and Risk of Postoperative Urinary Complications after Metabolic and Bariatric Surgery: A Multi-Institutional Study. | Obes Surg | 2025 | https://conductscience.org/library/papers/41175280 | PubMed |
| 41096426 | Sugammadex and Acceleromyography Used During a Lensectomy in a Sea Lion (Zalophus californianus). | Animals (Basel) | 2025 | https://conductscience.org/library/papers/41096426 | PubMed |
| 41071214 | Effects of sugammadex on the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic abdominal surgery: a randomized controlled study. | Surg Endosc | 2026 | https://conductscience.org/library/papers/41071214 | PubMed |
| 39118951 | Eliminating residual neuromuscular blockade: a literature review. | Ann Transl Med | 2024 | https://conductscience.org/library/papers/39118951 | PubMed |
| 36829738 | Ιnclusion Complexes of Magnesium Phthalocyanine with Cyclodextrins as Potential Photosensitizing Agents. | Bioengineering (Basel) | 2023 | https://conductscience.org/library/papers/36829738 | PubMed |
| 36569123 | Sugammadex versus neostigmine for neuromuscular blockade reversal in outpatient surgeries: A randomized controlled trial to evaluate efficacy and associated healthcare cost in an academic center. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36569123 | PubMed |
| 36561110 | Perioperative Efficiency of Sugammadex Following Laparoscopic Cholecystectomy in Clinical Practice. | Ochsner J | 2022 | https://conductscience.org/library/papers/36561110 | PubMed |
| 36561101 | Hawthorne Effect: More Than Just Telephones. | Ochsner J | 2022 | https://conductscience.org/library/papers/36561101 | PubMed |
| 36064986 | Effect of neuromuscular reversal with neostigmine/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery. | Tech Coloproctol | 2023 | https://conductscience.org/library/papers/36064986 | PubMed |
| 35925158 | [Anesthesia for thoracic surgery in a female patient with Ullrich congenital muscular dystrophy]. | Anaesthesiologie | 2022 | https://conductscience.org/library/papers/35925158 | PubMed |
| 35737717 | Modeling cortical synaptic effects of anesthesia and their cholinergic reversal. | PLoS Comput Biol | 2022 | https://conductscience.org/library/papers/35737717 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| ROCURONIUM | CHEMBL1201244 | Results | 1 | https://conductscience.org/library/drugs/CHEMBL1201244 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19468024
GET https://conductscience.org/api/papers/v1/19468024/cited_by?page=2